company background image
533543 logo

Brooks Laboratories BSE:533543 Stock Report

Last Price

₹127.95

Market Cap

₹3.9b

7D

-5.1%

1Y

28.6%

Updated

10 May, 2025

Data

Company Financials

Brooks Laboratories Limited

BSE:533543 Stock Report

Market Cap: ₹3.9b

533543 Stock Overview

Manufactures and sells pharmaceuticals in India and internationally. More details

533543 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Brooks Laboratories Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Brooks Laboratories
Historical stock prices
Current Share Price₹127.95
52 Week High₹202.80
52 Week Low₹72.51
Beta0.73
1 Month Change3.94%
3 Month Change-16.86%
1 Year Change28.59%
3 Year Change62.68%
5 Year Change351.32%
Change since IPO112.54%

Recent News & Updates

Recent updates

Shareholder Returns

533543IN Life SciencesIN Market
7D-5.1%-1.1%-1.6%
1Y28.6%42.4%1.7%

Return vs Industry: 533543 underperformed the Indian Life Sciences industry which returned 42.4% over the past year.

Return vs Market: 533543 exceeded the Indian Market which returned 1.7% over the past year.

Price Volatility

Is 533543's price volatile compared to industry and market?
533543 volatility
533543 Average Weekly Movement11.6%
Life Sciences Industry Average Movement8.0%
Market Average Movement7.2%
10% most volatile stocks in IN Market9.9%
10% least volatile stocks in IN Market4.8%

Stable Share Price: 533543's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: 533543's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
2002293n/awww.brookslabs.net

Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. The company offers liquid and dry powder injection, carbapenem dry powder injectables, tablets, oral suspension, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.

Brooks Laboratories Limited Fundamentals Summary

How do Brooks Laboratories's earnings and revenue compare to its market cap?
533543 fundamental statistics
Market cap₹3.90b
Earnings (TTM)-₹181.15m
Revenue (TTM)₹769.62m

5.1x

P/S Ratio

-21.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
533543 income statement (TTM)
Revenue₹769.62m
Cost of Revenue₹513.35m
Gross Profit₹256.26m
Other Expenses₹437.41m
Earnings-₹181.15m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-6.08
Gross Margin33.30%
Net Profit Margin-23.54%
Debt/Equity Ratio15.2%

How did 533543 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/10 06:39
End of Day Share Price 2025/05/09 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Brooks Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research